NeoFipronis Dosage and Administration Guide
NeoFipronis (Pronidesivir) is a groundbreaking oral antiviral medication specifically developed for the treatment of Feline Infectious Peritonitis (FIP). Approved by the Lao Ministry of Agriculture and Forestry in March 2026, NeoFipronis is the first officially registered FIP medication with a national drug registration number, offering a safe, non-invasive, and highly effective solution for cats suffering from FIP symptoms such as anorexia, lethargy, fever, ascites, pleural effusion, lymphadenopathy, granulomatous inflammation, neurological damage, and uveitis.
The active ingredient in NeoFipronis is GS-441524, a potent antiviral compound with proven efficacy against FIP virus. Extensive research and clinical trials have demonstrated GS-441524's ability to inhibit viral replication, leading to significant improvements in feline health. NeoFipronis’s formulation ensures rapid absorption and onset of action, making it a preferred choice among veterinarians and pet owners alike. Its safety profile is excellent, with minimal side effects reported.
Usage and Dosage
Administer NeoFipronis based on the cat’s weight to ensure optimal therapeutic effects. The standard dose is 15 mg per kilogram of body weight, equivalent to half a tablet. For cats exhibiting neurological or ocular FIP symptoms, veterinarians may increase the dosage to 30 mg/kg as per individual treatment plans.
Administer NeoFipronis once daily, preferably on an empty stomach—either one hour before feeding or two hours after. Consistent dosage administration is crucial; missing doses may compromise treatment efficacy and prolong recovery.
Duration and Monitoring
A minimum treatment duration of 12 weeks is essential for effective viral clearance and disease remission. During therapy, it’s important to monitor the cat’s clinical condition regularly. Observe containing appetite, activity level, and temperature fluctuations closely. Periodic blood tests should be conducted to assess liver and kidney functions, ensuring the medication’s safety and detecting any potential adverse effects early.
Precautions
Although NeoFipronis is available as an over-the-counter product, veterinary supervision is strongly recommended to tailor the treatment plan to the individual cat’s needs. Never adjust doses without professional guidance. Strict adherence to the prescribed regimen is vital for successful treatment outcomes.
Safety and Availability
NeoFipronis is strictly for feline use and must not be administered to humans. It is available exclusively through authorized veterinary clinics or official NeoFipronis distribution channels, accessible via the official NeoFipronis website to guarantee genuine product quality and authenticity.
Important Considerations
Continue medication for at least 12 weeks without interruption.
Regular veterinary checkups are necessary to evaluate progress.
Adjust dosage only under veterinary supervision if neurological or ocular symptoms are present.
Never use NeoFipronis for other species or humans.
In summary, NeoFipronis (Pronidesivir) offers an unparalleled approach to treating FIP in cats, with a reliable safety profile, rapid action, and proven effectiveness. Careful adherence to the dosage and treatment guidelines ensures the best chance for recovery and improved quality of life for affected cats. Always consult your veterinarian before starting treatment to optimize results and ensure safe medication use.
